<b> </b> Energy efficiency and gas volume comparison. by Ning Zuo (17295415)

Model validation of kinetic parameters. by Ning Zuo (17295415)

Changes in intraocular pressure (IOP) from before to after omidenepag isopropyl administration in different patient groups. by Kana Tokumo (21702784)

Ambient Air Pollutant Dynamics (2010–2025) and the Exceptional Winter 2016–17 Pollution Episode: Implications for a Uranium/Arsenic Exposure Event by Thomas Clemens Carmine (19756929)

“…Accompanying plots show 28-day running averages, and a table compares winter pollutant burdens (2015/16–2018/19), highlighting the extreme Winter 2016/17 episode and its potential link to a documented urinary U/As spike between March and May 2017.…”

Performance of different methods for controlling confounding in Felsenstein’s worst case. by Joshua G. Schraiber (8027060)

Impact of including phylogenetic eigenvectors on detection of coevolution of gene-expression levels in fungi. by Joshua G. Schraiber (8027060)

GRADE judgements. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

Basic characteristics of the included studies. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

The data of meta-analysis. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

Risk of bias. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

Overall risk of bias assessment. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

Funnel plot of VO_2Peak inclusion studies. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

Analysis of subgroups. by Da Huang (1306407)

“…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”

<i>Estimated metabolic rates among the simulation workflows</i>. by Israel Luis (13916706)

LA has minimal impact on HIV-1 virion integrity and surface levels of gp120 envelope protein. by Muriel Aldunate (22411177)

Metabolite concentrations and statistics for data displayed in Fig 8. by Zachary T. Hying (21512605)

The presence of lanthanum minimizes the lag phase and FA imbalance during the transition from formate to MeOH. by Zachary T. Hying (21512605)

The lag phase defect is specific to transitions that require the production of FA, and correlates with FA concentration. by Zachary T. Hying (21512605)

Virucidal activity of vaginal acids against HSV-2 and HPV-16. by Muriel Aldunate (22411177)

ExaF contributes to FA homeostasis by lowering the FA concentration. by Zachary T. Hying (21512605)